INSYS Therapeutics Inc.
Rank 37
About
Biotechnology company Insys Therapeutics specialises in cannabinoid research and novel drug delivery systems. Several of their products are in the preclinical stage of development, while SYNDROS and SUBSYS, the company’s flagship solutions, have been approved for patient care. The company’s head office is based in Chandler, Arizona.
$4.47
USD
2.61%
Market cap
$332,694,322
Total volume
$1,579,151
Shares outstanding
74,428,260
Rank 37
About
Biotechnology company Insys Therapeutics specialises in cannabinoid research and novel drug delivery systems. Several of their products are in the preclinical stage of development, while SYNDROS and SUBSYS, the company’s flagship solutions, have been approved for patient care. The company’s head office is based in Chandler, Arizona.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
INSY |
$1,579,151
|
100% |
$4.47
|
Chart